Synergism of a novel MCL-1 downregulator, acriflavine, with navitoclax (ABT-263) in triple-negative breast cancer, lung adenocarcinoma and glioblastoma multiforme

Lee, A; Jin, HO; Haque, MM; Kim, HY; Jung, H; Park, JH; Kim, I; Song, JY; Yoon, HK; Kim, HK; Han, J; Park, IC; Kim, KS; Park, SG

Park, SG (通讯作者),Inje Univ, Coll Med, Dept Microbiol & Immunol, 75 Bokji Ro St, Busan 47392, South Korea.;Kim, KS (通讯作者),Korea Inst Radiol & Med Sci, Div Radiat Biomed Res, 75 Nowon Ro, Seoul 01812, South Korea.

INTERNATIONAL JOURNAL OF ONCOLOGY, 2022; 60 (1):

Abstract

Myeloid cell leukemia sequence 1 (MCL-1), an anti-apoptotic B-cell lymphoma 2 (BCL-2) family molecule frequently amplified in various human cancer cel......

Full Text Link